463 related articles for article (PubMed ID: 31990981)
1. Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.
Conz L; Mota BS; Bahamondes L; Teixeira Dória M; Françoise Mauricette Derchain S; Rieira R; Sarian LO
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):970-982. PubMed ID: 31990981
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Romero SA; Young K; Hickey M; Su HI
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
6. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users.
Silva FR; Grande AJ; Lacerda Macedo AC; Colonetti T; Rocha MC; Rodrigues Uggioni ML; Silva BR; da Rosa MI
Clin Breast Cancer; 2021 Dec; 21(6):497-508. PubMed ID: 34045174
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies.
Heting M; Wenping L; Yanan W; Dongni Z; Xiaoqing W; Zhli Z
Heliyon; 2023 Apr; 9(4):e14733. PubMed ID: 37089342
[TBL] [Abstract][Full Text] [Related]
9. Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review.
Zürcher A; Knabben L; Janka H; Stute P
Arch Gynecol Obstet; 2023 Jun; 307(6):1747-1761. PubMed ID: 35716207
[TBL] [Abstract][Full Text] [Related]
10. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
11. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Sturridge F; Guillebaud J
Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
[TBL] [Abstract][Full Text] [Related]
12. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E
Acta Oncol; 2016 Nov; 55(11):1281-1284. PubMed ID: 27148621
[TBL] [Abstract][Full Text] [Related]
13. Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study.
Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Joensuu H; Pukkala E
Acta Oncol; 2016; 55(2):188-92. PubMed ID: 26243443
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
Krashin J; Tang JH; Mody S; Lopez LM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
[TBL] [Abstract][Full Text] [Related]
15. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
16. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.
Fu Y; Zhuang Z
Int J Clin Exp Pathol; 2014; 7(10):6419-29. PubMed ID: 25400720
[TBL] [Abstract][Full Text] [Related]
18. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
Wan YL; Holland C
Climacteric; 2011 Dec; 14(6):622-32. PubMed ID: 22017273
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Al-Inany HG; Farquhar CM
Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
